Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C52H74N14O12S2 |
| Molecular Weight | 1151.361 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC2=O)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)C=C1
InChI
InChIKey=QVQOGNOOAMQKCE-ZTYVOHGWSA-N
InChI=1S/C52H74N14O12S2/c1-78-32-16-14-31(15-17-32)25-35-46(73)63-36(24-30-10-4-2-5-11-30)47(74)61-34(18-19-40(53)67)45(72)64-37(26-41(54)68)48(75)65-38(29-79-80-52(27-43(70)60-35)20-6-3-7-21-52)50(77)66-23-9-13-39(66)49(76)62-33(12-8-22-58-51(56)57)44(71)59-28-42(55)69/h2,4-5,10-11,14-17,33-39H,3,6-9,12-13,18-29H2,1H3,(H2,53,67)(H2,54,68)(H2,55,69)(H,59,71)(H,60,70)(H,61,74)(H,62,76)(H,63,73)(H,64,72)(H,65,75)(H4,56,57,58)/t33-,34-,35-,36-,37-,38-,39-/m0/s1
| Molecular Formula | C52H74N14O12S2 |
| Molecular Weight | 1151.361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. | 2000-10 |
|
| Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding. | 2000-07 |
|
| Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. | 1998-12 |
|
| Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. | 1998-01 |
|
| Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist. | 1997-10-17 |
|
| The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. | 1997-10 |
|
| 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. | 1997-06-01 |
|
| Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells. | 1995 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:30:33 GMT 2025
by
admin
on
Mon Mar 31 18:30:33 GMT 2025
|
| Record UNII |
FFM269698K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FFM269698K
Created by
admin on Mon Mar 31 18:30:33 GMT 2025 , Edited by admin on Mon Mar 31 18:30:33 GMT 2025
|
PRIMARY | |||
|
9833460
Created by
admin on Mon Mar 31 18:30:33 GMT 2025 , Edited by admin on Mon Mar 31 18:30:33 GMT 2025
|
PRIMARY | |||
|
DTXSID601034755
Created by
admin on Mon Mar 31 18:30:33 GMT 2025 , Edited by admin on Mon Mar 31 18:30:33 GMT 2025
|
PRIMARY | |||
|
73168-24-8
Created by
admin on Mon Mar 31 18:30:33 GMT 2025 , Edited by admin on Mon Mar 31 18:30:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
BINDING
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
